SCHEMBL22340329

SCHEMBL22340329

Cc1ccc(S(=O)(=O)Sc2occc(=O)c2C)cc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 1/20 0.50
G6PD P11413 2/20 0.40
GAA P10253 2/20 0.37
BCHE P06276 9/20 0.36
ACHE P22303 9/20 0.36
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA12 O43570 1/20 0.35
CA3 P07451 1/20 0.35
CA6 P23280 1/20 0.35
CA5A P35218 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA5B Q9Y2D0 1/20 0.35
TLR9 Q9NR96 1/20 0.34
POLB P06746 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PTGS2 P35354 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22340327 0.72 KDM4E (0.43) GAA
SCHEMBL3917191 0.68 DNMT1 (1.00) DNMT1G6PDGAABCHEACHE
SCHEMBL2038233 0.65 DNMT1 (0.64) DNMT1G6PDGAABCHEACHE
SCHEMBL733650 0.65 DNMT1 (0.64) DNMT1G6PDGAABCHEACHE
SCHEMBL10330809 0.64 DNMT1 (0.81) DNMT1G6PDGAABCHEACHE
SCHEMBL7271430 0.63 DNMT1 (0.61) DNMT1G6PDGAABCHEACHE
SCHEMBL9985987 0.62 CA12 (0.48) GAACA2CA12SMN1; SMN2
SCHEMBL11290816 0.62 DNMT1 (0.60) DNMT1G6PDGAABCHEACHE
SCHEMBL16693835 0.62 DNMT1 (0.59) DNMT1G6PDGAABCHEACHE
SCHEMBL29384596 0.62 DNMT1 (0.59) DNMT1G6PDGAABCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10927135-B2 Metal-free direct arylation of dialkyl phosphonates for the synthesis of mixed alkyl aryl phosphonates THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS (US) 2021-02-23 US disclosed
US-20200255461-A1 METAL-FREE DIRECT ARYLATION OF DIALKYL PHOSPHONATES FOR THE SYNTHESIS OF MIXED ALKYL ARYL PHOSPHONATES THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2020-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200255461-A1 METAL-FREE DIRECT ARYLATION OF DIALKYL PHOSPHONATES FOR THE SYNTHESIS OF MIXED ALKYL ARYL PHOSPHONATES SLC35B2, PPIP5K2, PPA1 DNMT1 3920/4885G6PD 749/4885GAA 1787/4885
US-10927135-B2 Metal-free direct arylation of dialkyl phosphonates for the synthesis of mixed alkyl aryl phosphonates SLC35B2, PPIP5K2, PPA1 DNMT1 3920/4885G6PD 749/4885GAA 1787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.